(Reuters) -Pfizer filed a second lawsuit on Monday accusing Danish drugmaker Novo Nordisk of structuring its $9 billion bid for biotech Metsera to stall, not close, the deal, a tactic it said is designed to suppress competition in obesity drugs.  Novo and Metsera on Monday rejected Pfizer's claims, in a dramatic escalation in the legal and bidding fight for control...

Nov 3 (Reuters) - * CANTOR EQUITY PARTNERS V- PRICED ITS UPSIZED INITIAL PUBLIC OFFERING OF 22,000,000 CLASS A ORDINARY SHARES AT $10.00 PER SHARE Source text: Further company coverage: [ ] ...

Tinybeans ( TNYYF ) accelerates innovation in privacy-first, secure family memory-keeping SYDNEY, Nov. 3, 2025 /PRNewswire/ -- Tinybeans Group ( TNYYF ) , the global privacy-first family photo-sharing and journaling app, today announced the acquisition of the assets of Qeepsake Inc., a Boston-based digital journaling platform loved by U.S. parents for its text-prompt memory capture. The US$2.7 million all-stock...

* Lawsuit alleges Novo's 30-month closing period would stall Metsera's ( MTSR ) obesity drug * Metsera ( MTSR ) says Pfizer ( PFE ) using litigation to lower its takeover price * Judge will analyze claims on Tuesday By Sabrina Valle, Mrinalika Roy and Tom Hals Nov 3 (Reuters) - Pfizer ( PFE ) filed a second lawsuit on...